← Leaderboards
Theresa Guo
University Of California, San Diego
$470,834
Attributed
$470,834
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $235.4K · FY2024–25$250K$187.5K$125K$62.5K$0
'24
'25
Funding mix
By agency
NIH$470,834 · 1
By mechanism
K08$470,834 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- J. Silvio Gutkind$14,229,551
- Joseph R Ecker$49,726,626
- Jared William Young$14,211,149
- Dyann F Wirth$23,065,036
- Andrew B. Sharabi$3,226,792
Others in their field
Other Rising Stars on “Algorithms”
- Maximilian Haeussler · University Of California Santa Cruz$14,765,386
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Suma Babu · Massachusetts General Hospital$11,004,714
Research focus
AlgorithmsAlternative SplicingAntigensAntigen TargetingAnti-Pd1 TherapyAutomobile DrivingBindingBiobankBlood SpecimenCancer CellCancer ModelCancer PatientCancer TherapyCancer VaccinesCandidate IdentificationCareerCellsCheckpoint TherapyClinicClinical TrialsCombined Modality TherapyComputational PipelinesComputing MethodologiesAffinity
Grant awards (2)
Identification of splice variant derived neo-antigens in head and neck squamous cell carcinoma as targets for tumor vaccine therapy$235,417
K08 · FY2025 · CA · contact PI
Identification of splice variant derived neo-antigens in head and neck squamous cell carcinoma as targets for tumor vaccine therapy$235,417
K08 · FY2024 · CA · contact PI